Advances in synthetic peptide immuno-regulatory epitopes
Open Access
- 1 January 2014
- journal article
- review article
- Published by Elsevier BV in World Allergy Organization Journal
- Vol. 7 (1), 1-30
- https://doi.org/10.1186/1939-4551-7-30
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cat peptide antigen desensitisation for treating cat allergic rhinoconjunctivitisExpert Opinion on Investigational Drugs, 2013
- Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell EpitopesJournal of Allergy and Clinical Immunology, 2012
- Mechanisms of immunotherapy to aeroallergensClinical & Experimental Allergy, 2011
- Immunotherapy with peptidesAllergy, 2011
- Developments in allergen‐specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen‐specific immunoglobulin E and T cell reactivityClinical & Experimental Allergy, 2010
- Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppressionThe Journal of Experimental Medicine, 2009
- Immunomodulation of Allergic DiseaseAnnual Review of Medicine, 2009
- Immunotherapy with Allergen PeptidesAllergy, Asthma & Clinical Immunology, 2007
- T Cell Epitope Immunotherapy Induces a CD4+ T Cell Population with Regulatory ActivityPLoS Medicine, 2005
- Cat allergen peptide immunotherapy reduces CD4+ T cell responses to cat allergen but does not alter suppression by CD4+ CD25+ T cells: a double‐blind placebo‐controlled studyAllergy, 2004